Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shigeki Hoshino is active.

Publication


Featured researches published by Shigeki Hoshino.


Journal of Leukocyte Biology | 2010

HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency

Shigeki Hoshino; Mitsuru Konishi; Masako Mori; Mari Shimura; Chiaki Nishitani; Yoshio Kuroki; Yoshio Koyanagi; Shigeyuki Kano; Hiroyuki Itabe; Yukihito Ishizaka

Vpr, a HIV‐1 accessory protein, was believed to be present in the plasma of HIV‐1‐positive patients, and our previous work demonstrated the presence of plasma Vpr in 20 out of 52 patients. Interestingly, our data revealed that patients’ viral titer was correlated with the level of Vpr detected in their plasma. Here, we first show that rVpr, when incubated with human monocytes or MDMs, caused viral production from latently infected cells, and IL‐6 was identified as a responsible factor. The induction of IL‐6 by rVpr was dependent on signaling through TLR4 and its adaptor molecule, MyD88. We next provide evidence that rVpr induced the formation of OxPC and that a mAb against OxPC blocked rVpr‐induced IL‐6 production with the concomitant attenuation of MAPK activation. Moreover, the addition of NAC, a scavenger of ROS, abrogated the rVpr‐induced formation of OxPC, the phosphorylation of C/EBP‐β, a substrate of MAPK, and IL‐6 production. As rIL‐6 reactivated viral replication in latently infected cells, our data indicate that rVpr‐induced oxidative stress triggers cell‐based innate immune responses and reactivates viral production in latently infected cells via IL‐6 production. Our results suggest that Vpr should be monitored based on the viral titer, and they provide the rationale for the development of novel, anti‐AIDS therapeutics targeting Vpr.


Journal of Virology | 2008

Human Immunodeficiency Virus Type 1 Vpr Inhibits Axonal Outgrowth through Induction of Mitochondrial Dysfunction

Hiroko Kitayama; Yoshiharu Miura; Yoshinori Ando; Shigeki Hoshino; Yukihito Ishizaka; Yoshio Koyanagi

ABSTRACT Human immunodeficiency virus type 1 (HIV-1)-infected macrophages damage mature neurons in the brain, although their effect on neuronal development has not been clarified. In this study, we show that HIV-1-infected macrophages produce factors that impair the development of neuronal precursor cells and that soluble viral protein R (Vpr) is one of the factors that has the ability to suppress axonal growth. Cell biological analysis revealed that extracellularly administered recombinant Vpr (rVpr) clearly accumulated in mitochondria where a Vpr-binding protein adenine nucleotide translocator localizes and also decreased the mitochondrial membrane potential, which led to ATP synthesis. The depletion of ATP synthesis reduced the transportation of mitochondria within neurites. This mitochondrial dysfunction inhibited axonal growth even when the frequency of apoptosis was not significant. We also found that point mutations of arginine (R) residues to alanine (A) residues at positions 73, 77, and 80 rendered rVpr incapable of causing mitochondrial membrane depolarization and axonal growth inhibition. Moreover, the Vpr-induced inhibition was suppressed after treatment with a ubiquinone analogue (ubiquinone-10). Our results suggest that soluble Vpr is a major viral factor that causes a disturbance in neuronal development through the induction of mitochondrial dysfunction. Since ubiquinone-10 protects the neuronal plasticity in vitro, it may be a therapeutic agent that can offer defense against HIV-1-associated neurological disease.


Journal of Virology | 2013

Identification of a Novel Subgroup of Koala Retrovirus from Koalas in Japanese Zoos.

Takayuki Shojima; Rokusuke Yoshikawa; Shigeki Hoshino; Sayumi Shimode; So Nakagawa; Takuji Ohata; Rie Nakaoka; Takayuki Miyazawa

ABSTRACT We identified a new subgroup of koala retrovirus (KoRV), named KoRV-J, which utilizes thiamine transport protein 1 as a receptor instead of the Pit-1 receptor used by KoRV (KoRV-A). By subgroup-specific PCR, KoRV-J and KoRV-A were detected in 67.5 and 100% of koalas originating from koalas from northern Australia, respectively. Altogether, our results indicate that the invasion of the koala population by KoRV-J may have occurred more recently than invasion by KoRV-A.


Journal of Virology | 2013

Construction and characterization of an infectious molecular clone of koala retrovirus

Takayuki Shojima; Shigeki Hoshino; Masumi Abe; Jiro Yasuda; Hiroko Shogen; Takeshi Kobayashi; Takayuki Miyazawa

ABSTRACT Koala retrovirus (KoRV) is a gammaretrovirus that is currently endogenizing into koalas. Studies on KoRV infection have been hampered by the lack of a replication-competent molecular clone. In this study, we constructed an infectious molecular clone, termed plasmid pKoRV522, of a KoRV isolate (strain Aki) from a koala reared in a Japanese zoo. The virus KoRV522, derived from pKoRV522, grew efficiently in human embryonic kidney (HEK293T) cells, attaining 106 focus-forming units/ml. Several mutations in the Gag (L domain) and Env regions reported to be involved in reduction in viral infection/production in vitro are found in pKoRV522, yet KoRV522 replicated well, suggesting that any effects of these mutations are limited. Indeed, a reporter virus pseudotyped with pKoRV522 Env was found to infect human, feline, and mink cell lines efficiently. Analyses of KoRV L-domain mutants showed that an additional PPXY sequence, PPPY, in Gag plays a critical role in KoRV budding. Altogether, our results demonstrate the construction and characterization of the first infectious molecular clone of KoRV. The infectious clone reported here will be useful for elucidating the mechanism of endogenization of the virus in koalas and screening for antiretroviral drugs for KoRV-infected koalas.


Retrovirology | 2013

Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1.

Kenta Iijima; Noriyuki Okudaira; Masato Tamura; Akihiro Doi; Yoshikazu Saito; Mari Shimura; Motohito Goto; Akihiro Matsunaga; Yuki I. Kawamura; Takeshi Otsubo; Taeko Dohi; Shigeki Hoshino; Shigeyuki Kano; Shotaro Hagiwara; Junko Tanuma; Hiroyuki Gatanaga; Masanori Baba; Taku Iguchi; Motoko Yanagita; Shinichi Oka; Tadashi Okamura; Yukihito Ishizaka

BackgroundViral protein R (Vpr), a protein of human immunodeficiency virus type-1 (HIV-1) with various biological functions, was shown to be present in the blood of HIV-1-positive patients. However, it remained unclear whether circulating Vpr in patients’ blood is biologically active. Here, we examined the activity of blood Vpr using an assay system by which retrotransposition of long interspersed element-1 (L1-RTP) was detected. We also investigated the in vivo effects of recombinant Vpr (rVpr) by administrating it to transgenic mice harboring human L1 as a transgene (hL1-Tg mice). Based on our data, we discuss the involvement of blood Vpr in the clinical symptoms of acquired immunodeficiency syndrome (AIDS).ResultsWe first discovered that rVpr was active in induction of L1-RTP. Biochemical analyses revealed that rVpr-induced L1-RTP depended on the aryl hydrocarbon receptor, mitogen-activated protein kinases, and CCAAT/enhancer-binding protein β. By using a sensitive L1-RTP assay system, we showed that 6 of the 15 blood samples from HIV-1 patients examined were positive for induction of L1-RTP. Of note, the L1-RTP-inducing activity was blocked by a monoclonal antibody specific for Vpr. Moreover, L1-RTP was reproducibly induced in various organs, including the kidney, when rVpr was administered to hL1-Tg mice.ConclusionsBlood Vpr is biologically active, suggesting that its monitoring is worthwhile for clarification of the roles of Vpr in the pathogenesis of AIDS. This is the first report to demonstrate a soluble factor in patients’ blood active for L1-RTP activity, and implies the involvement of L1-RTP in the development of human diseases.


Journal of General Virology | 2011

Mapping of a neutralizing epitope in the surface envelope protein of porcine endogenous retrovirus subgroup B.

Yuki Nakaya; Shigeki Hoshino; Jiro Yasuda; Takayuki Miyazawa

Pigs are thought to be the most suitable donor animal for xenotransplantation. However, pigs harbour potentially hazardous infectious agents, termed porcine endogenous retroviruses (PERVs), in their genome. In this study, we generated a mAb against PERV-B surface (SU) envelope protein (Env), designated KRT1. KRT1 binding was detected by an indirect immunofluorescence assay and flow cytometric analysis on cells infected with PERV-B. KRT1 neutralized PERV-B pseudotype virus and specifically recognized PERV-B SU Env, but not PERV-A SU Env by immunoblotting analysis. The peptide-ELISA revealed that KRT1 recognized a linear peptide sequence (ALEPPHNLPVP) residing in a proline-rich region that is one of the subdomains of SU Env. In conclusion, the KRT1 antibody will serve as a useful tool for the study of PERV-B and, more importantly, it may provide new protective strategies against PERV-B infection in xenotransplantation.


Microbiology and Immunology | 2013

Identification of cellular factors required for the budding of koala retrovirus

Sayumi Shimode; Rie Nakaoka; Shigeki Hoshino; Masumi Abe; Hiroko Shogen; Jiro Yasuda; Takayuki Miyazawa

Koala retrovirus (KoRV) is a unique gammaretrovirus that is currently endogenizing into its host and considered to be associated with leukemia, lymphoma and immunosuppression in koalas (Phascolactos cinereus). In this study, it was demonstrated that WWP2 or WWP2‐like E3 ubiquitin ligases possessing the WW domain closely related to WWP2 and Vps4A/B are involved in KoRV budding. These data suggest that KoRV Gag recruits the cellular endosomal sorting complex required for transport machinery through interaction of the PPPY L‐domain with the WW domain(s) of WWP2 and that progeny virions are released from cells by utilizing the multivesicular body sorting pathway.


AIDS Research and Human Retroviruses | 2007

Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers.

Shigeki Hoshino; Binlian Sun; Mitsuru Konishi; Mari Shimura; Tatsuya Segawa; Yoshiaki Hagiwara; Yoshio Koyanagi; Aikichi Iwamoto; Junichi Mimaya; Hiroshi Terunuma; Shigeyuki Kano; Yukihito Ishizaka


Biochemical and Biophysical Research Communications | 2005

Improved gene expression in resting macrophages using an oligopeptide derived from Vpr of human immunodeficiency virus type-1.

Izuru Mizoguchi; Yoshihiro Ooe; Shigeki Hoshino; Mari Shimura; Tadashi Kasahara; Shigeyuki Kano; Toshiko Ohta; Fumimaro Takaku; Yasuhide Nakayama; Yukihito Ishizaka


Virus Genes | 2012

Sequence comparison of three infectious molecular clones of RD-114 virus

Sayumi Shimode; Rokusuke Yoshikawa; Shigeki Hoshino; Yuki Nakaya; Shoichi Sakaguchi; Takeshi Kobayashi; Takayuki Miyazawa

Collaboration


Dive into the Shigeki Hoshino's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yukihito Ishizaka

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Mari Shimura

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge